Potentially replacing the traditional cocktail drug approach, a team from the University of Minnesota's Center for Drug Design have developed a new method to combat HIV/AIDS.

The new approach - proven accurate in lab tests - merges the features of two antiviral agents into one drug, achieving the same effect as when two or more drugs are taken separately. The cocktail approach most commonly prescribed to HIV-infected patients is expensive and high in Toxicity because many drugs are taken at one time.

The new concept is named Portmanteau Inhibitors by the researchers.

Study results were published in a July 4 issue of the Journal of Medicinal Chemistry.

Find more details from the full report.